# Biological Therapy in Treating Patients With Metastatic Cancer

> **NCT00002733** · PHASE2 · COMPLETED · sponsor: **Hoag Memorial Hospital Presbyterian** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Cancer
- Melanoma (Skin)
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** therapeutic tumor infiltrating lymphocytes
- **DRUG:** cimetidine

## Key facts

- **NCT ID:** NCT00002733
- **Lead sponsor:** Hoag Memorial Hospital Presbyterian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** 2000-01
- **Final completion:** 2000-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002733, "Biological Therapy in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*